Eicosapentaenoic acid (EPA) is a beneficial omega-3 fatty acid known for its various health benefits, especially in supporting heart health and reducing inflammation in the body. Biotechnological production of EPA involves using microorganisms like algae or genetically modified yeast to produce this fatty acid in a controlled environment. By harnessing biotechnological methods, EPA production can be more sustainable, cost-effective, and scalable compared to traditional methods like fish oil extraction. This process allows for the production of high-quality EPA with fewer environmental impacts and better control over purity and concentration. Overall, the biotechnological production of EPA presents a promising avenue for meeting the growing demand for this essential nutrient while also promoting sustainability and innovation in the field of nutritional supplements.